The distribution of camptothecin (CPT)-induced break points in late S or G 2 phase of the cell cycle observed in Chinese hamster chromosomes was analysed in 400 metaphases. Contrary to expectation, they were not localized in the heterochromatic regions, suggesting that these chromatid-type aberrations arise by a mechanism which does not involve collision of the CPT-trapped 'cleavable complex' with the replication fork. Since many break points mapped more frequently to light bands (DAPI negative) than dark bands (DAPI positive) with a frequency of 73 and 15% respectively, it could be argued that the presence of the CPT-trapped 'cleavable complex' probably interferes with chromatin condensation. In fact, the euchromatic regions, which are expected to be more actively condensed in G 2 phase, were more involved in chromosomal damage. These results do not completely confirm the idea that some residual DNA synthesis occurring in G 2 is responsible for the G2 clastogenic effects of CPT as the heterochromatic regions should, in this case, be more involved.
Introduction
DNA topoisomerases are enzymes involved in DNA replication, recombination, chromatid segregation and transcription (Wang, 1985; D'Arpa and Liu, 1989) . DNA topoisomerase I (topo I) breaks and rejoins one strand of the DNA double helix, whereas DNA topoisomerase II (topo II) catalyses the breakage and rejoining of both DNA strands. These enzymes produce transient DNA breaks through which other DNA strands can pass and the result is interconversion between topological isomers of DNA.
A covalent protein-DNA intermediate is formed during each cycle of DNA strand breakage and reunion, (Zwelling et al., 1981) . This protein-DNA intermediate has been termed the 'cleavable complex'. Up to the present, a wide spectrum of drugs which can interfere with the breakage-reunion reaction catalysed by DNA topoisomerases have been studied. These anti-topoisomerase drags act via trapping or stabilizing the 'cleavable complex' (Smith, 1990; Ross, 1985) . Anti-topoisomerase drugs can be classified as clastogenic agents which have an indirect mechanism of action compared with those which induce damage directly to DNA (Palitti et al, 1990; Scott et al., 1991) . DNA breaks induced by anti-topoisomerase drugs are formed by an enzyme-mediated process and, being protein concealed, they can be detected by DNA filter elution only if the cell lysate is digested with a proteinase before elution (Zwelling et al., 1981; Zwelling, 1985; Glisson and Ross, 1987) . Inhibitors of both DNA topo I and II act by stabilizing the DNA-topoisomerase complex known as the 'cleavable complex': in the topo II reaction both single and double DNA strand breaks (SSBs and DSBs) are formed, while in the topo I reaction only DNA SSBs are generated. Inhibitors of DNA topo II which give rise to DNA DSBs are able to induce chromosomal aberrations in all phases of the cell cycle, acting by an 'S-independent' mechanism, similar to ionizing radiation. However, they are also able to induce sister chromatid exchanges (SCEs) when the treatment is performed in the S phase of the cell cycle (Dillehay et al, 1983; Andersson and Kihlman, 1989; Palitti et al., 1990) .
Only camptothecin (CPT) and its derivatives are known to inhibit topo I (D' Arpa and Liu, 1989) , giving rise to DNA SSBs only. Treatment with the topo I inhibitor CPT in human lymphocytes gives rise exclusively to chromatid-type aberrations when the drug is present in the S and G2 phases of the cell cycle. G\ treatment has no effect (Degrassi et al., 1989 ). An elevated frequency of SCEs is also observed, provided that treatment with CPT is performed during S phase (Degrassi et al., 1989) . Trapping of the 'cleavable complex' by the topo I inhibitor CPT gives rise only to SSBs, which per se are not expected to produce chromosomal aberrations. The chromatid-type aberrations obtained after S phase treatment would be the result of DNA DSBs derived from collision of the CPT-trapped 'cleavable complex' with the replication fork (D'Arpa and Liu, 1989; Hsiang et al., 1989; Zhang et al., 1990; Ryan et al, 1991) . The finding that CPT also induces chromatid aberrations during the G2 phase (Degrassi et al, 1989 ) is unexpected, as no DNA synthesis should occur during this phase. This finding was also confirmed in Chinese hamster cells (Palitti et al, 1990 and in root tips of Viciafaba (Andersson and Kihlman, 1992) .
Considering that the mechanism of action of CPT is •Statistically significant at P < 0.01. b Statistically significant at P < 0.005. Statistically significant at P < 0.001. Kihlman, 1992; Palitti et al., 1994) . In support of this hypothesis there is biochemical evidence which demonstrated that DNA newly synthesized during S phase does not achieve the entire chromatid length until the cells have progressed far into G 2 ( Van't Hof, 1980) . Furthermore, G 2 post-treatment with inhibitors of DNA synthesis potentiates induction of chromatid-type aberrations and SCEs in cells treated in G| or S phase with 'S-dependent agents', supporting the idea of the presence of residual DNA synthesis in G 2 (Andersson, 1983; PaJitti et al., 1984) . In order to further study induction of chromosomal damage in the G 2 phase by CPT, an investigation of the localization of chromatid aberrations was performed using a primary Chinese hamster cell line in which it is possible to easily distinguish between euchromatic and heterochromatic regions along the chromosomes. Schmid and Leppert (1969) , studying the replication pattern of chromosomes in Chinese hamster, revealed that the entire long arm of the X chromosome, the entire Y chromosome, parts of chromosomes 9 and 10 and the short arms of chromosomes 5-7 were late replicating. On this basis, whenever DNA synthesis is involved in G 2 CPT clastogenic effects one would expect localization of aberrations preferentially in the heterochromatic regions which are late replicating.
The results of such an analysis are presented in this paper.
Materials and methods

Cell culture
Primary Chinese hamster embryonic (CHE) cells, derived from a I2week-old embryo, were cultured in Ham's F10 medium supplemented with 15* fetal calf serum and antibiotics in a humidified atmosphere containing 5* CO 2 at 37°C as previously described (Balajee et al.. 1994) . Experiments were performed using CHE cells in passages 10-12. line was estimated using 5-bromo-2'-deoxyuridinc (BrdU) and mouse antiBrdU antibody conjugated with the fluorochrome FTTC. It was ~2 h.
Chemicals CPT (Sigma) was dissolved in dimethylsulfoxide (DMSO; Sigma) as a stock concentration of 2.5 mM and stored frozen at -20°C.
Treatments with CPT in late S and G 2 of the cell cycle
Treatments with CPT, at a dose level of 5 (iM, were carried out according to the experimental schedule shown in Figure 1 . B and C correspond to treatments in late S. CPT (5 nM) was added for 1 h. At the end of treatment the cells were washed twice with phosphate-buffered saline (PBS) and were left to recover in culture medium for 2 or 1 h respectively. Two hours before harvesting colcemid (10 nM) was added to the cultures (Figure 1 ). D and E correspond to treatments in the G 2 phase of the cell cycle. CPT (5 |lM) was added to the cultures together with colcemid (10 |iM) for 2 or 1 h respectively before harvesting. 
Preparation and scoring of chromosomes in metaphase
Hypotonic treatment (0.075 M KC1) and fixation were carried out according to standard procedures. Air-dried preparations were stained with Giemsa (3%) for 5 min. For each experimental point 400 metaphases were scored to analyse the distribution of aberrations among the individual chromosomes. Chromosome aberrations were classified according to Savage (1976) . To locate break points in euchromatic and heterochromatic regions some slides were stained with 20 }lg/ml 4,6-diamino-2-phenyl indole (DAPI) for 2 min (Slijepcevic and Natarajan, 1994a). DAPI banding was visualized using a computer controlled Zeiss epifluorescence microscope equipped with a cooled charge coupled device (CDD) camera. The digitized DAPI banding pattern was converted into a G banding pattern by inverting the contrast.
Statistical analyses
These were performed using the x 2 test.
Results
The results obtained from scoring 400 metaphases for each different CPT treatment are presented in Table I . The aberrations found were almost exclusively chromatid breaks, with very few chromatid-type exchanges. Since the frequency of chromatid exchange was very low they were evaluated as two breaks, one for each chromosome involved. The gaps were not included in scoring of aberrations. In Table I the total number of aberrations observed for all chromosomes and the yield of aberrations per individual chromosome, observed and expected, on the basis of their relative length (Savage and Papworth, 1982; Savage, 1991; Slijepcevic and Natarajan, 1994b) are also presented. The expected frequencies of aberrations were calculated assuming that CPT-induced break points are randomly distributed throughout the genome. The difference between observed and expected frequencies of break points was tested by x 2 analysis (Table I) . Table II shows the calculated incidences (%) of aberrations observed in individual chromosomes in order to directly compare the percentage of the genome represented by each chromosome with the percentage of aberrations observed in each of them. For a better understanding of the results the same set of data is represented graphically in turn for each treatment (Figures 2-5) .
From analysis of the data it clearly emerges that the distribution of CPT-induced break points among the different chromosomes is not random. This observation is valid independently of treatment regime: late S phase (B and C treatments) or G 2 (D and E treatments). Chromosomes 1 and 3, which are essentially euchromatic, showed a significantly higher number of breaks than expected on the basis of their DNA content. This finding was markedly higher in G 2 than in late S phase treatments. In contrast, chromosomes X and Y, which are very rich in heterochromatin, have a lower number of breaks than expected. Also, in this case the difference was higher in G 2 than in late S phase treatments. For chromosomes 9 and 10, which are also heterochromatic, the number of break points observed was less than expected. In the G 2 treatments it achieved statistical significance.
In Figure 6 the chromosomal locations of 355 chromosomal aberrations (breaks and exchanges) induced by G 2 CPT treatment in chromosomes 1-4, analysed from DAPI banded metaphases, is reported. The analysis was restricted to only these chromosomes because they were mostly involved in CPT-induced aberrations and also because their banding patterns were easily recognized. The results show that break points mapped to light bands more frequently than dark bands (73 and 15% respectively). The remaining 12% mapped to band junctions.
Discussion
The results obtained confirm that CPT treatment in G 2 induces chromatid-type aberrations.
Contrary to expectation, most of the break points observed after CPT treatments in late S or G 2 were not localized in heterochromatic regions This finding suggests that these aberrations could arise by a mechanism which does not involve collision of the CPT-trapped 'cleavable complex' with the replication fork or that they could be generated as a consequence of G 2 DNA synthesis not detected as late replicating.
In the G 2 phase of the cell cycle at least three processes 260 could be relevant for formation of chromatid aberrations: (i) DNA repair, (ii) DNA synthesis and (iii) chromatin condensation (Palitti et aL, 1983) . Results of G 2 phase experiments in root tips of Vicia faba with CPT and 5-fluorodeoxyuridine, an inhibitor of DNA synthesis, suggest that DNA synthesis is required for the clastogenic effects of CPT in the G 2 phase (Andersson and Kihlman, 1992) . This has been confirmed in Chinese hamster cells as well as by the observation that pretreatment with aphidicolin, an inhibitor of DNA polymerase, reduces CPT-induced aberrations in the G 2 phase .
The results obtained in this study do not completely support the idea that residual DNA synthesis occurring in G 2 is responsible for the clastogenic effects of CPT in the G 2 phase, since the heterochromatic regions should be involved more frequently. The third important process occurring in G 2 which could be relevant for formation of chromatid aberrations is chromatin condensation. Palitti et al. (1990) suggested that production of chromatid aberrations by CPT could be attributed to the peculiar type of single-strand breaks (i.e. protein concealed) and to the fact that the inhibitor is not removed until the cells enter mitosis. At present it can also be said that presence of the CPT-trapped 'cleavable complex' probably interferes with chromatin condensation. In fact, the euchromatic regions, which are actively condensed in G 2 , appear to be more involved in chromosomal damage.
